<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02366676</url>
  </required_header>
  <id_info>
    <org_study_id>2013-07-170</org_study_id>
    <nct_id>NCT02366676</nct_id>
  </id_info>
  <brief_title>Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract</brief_title>
  <official_title>Efficacy of Combined Intravesical Therapy With Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to Escherichia Coli Extract: a Multicenter, Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the efficacy of Combined Intravesical Therapy With
      Hyaluronic Acid and Chondroitin Sulphate in the Treatment of Recurrent Cystitis Refractory to
      Escherichia Coli Extract
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2014</start_date>
  <completion_date type="Anticipated">February 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The number of recurrence for recurrent cystitis</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Time interval of cystitis</measure>
    <time_frame>12months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The score change of UTI symptom Assessment questionnaire(UTISA)</measure>
    <time_frame>12months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Global Respone assessment(GRA) score assessment</measure>
    <time_frame>12 month after treatment</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">164</enrollment>
  <condition>Recurrent Cystitis</condition>
  <arm_group>
    <arm_group_label>Recurrent Cystitis group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients with Recurrent Cystitis Refractory to Escherichia Coli Extract</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>IALURIL</intervention_name>
    <description>IALURIL Intravesical instillation with cystoscope ( 1st month: once a week, 2nd~5th month:once a month)</description>
    <arm_group_label>Recurrent Cystitis group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. female aged 18 yrs or greater

          2. Patients diagnosed with recurrent cystitis and treated with Escherichia Coli Extract

          3. Patients with Refractory to Escherichia Coli Extract treatment

        Exclusion Criteria:

          1. child-bearing potential, pregnant or nursing women.

          2. Residual urine volume &gt;100ml

          3. genitourinary tuberculosis or cancer / anatomical abnomality of genitourinary tract /
             neurologic abnormality of low urinary tract.

          4. history of treatment for acute cystitis within 2weeks.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Kyu-Sung Lee, M.D., Ph.D.</last_name>
    <phone>82-2-3410-3554</phone>
    <email>keleedr@skku.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hyun Wook You, M.D.</last_name>
    <phone>82-2-3410-1268</phone>
    <email>khdoct29@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul,</city>
        <zip>130-710</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun Wook You, M.D.</last_name>
      <phone>82-2-3410-1268</phone>
      <email>khdoct29@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Kyu-Sung Lee, Ph.D, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 12, 2015</study_first_submitted>
  <study_first_submitted_qc>February 18, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 19, 2015</study_first_posted>
  <last_update_submitted>February 18, 2015</last_update_submitted>
  <last_update_submitted_qc>February 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Samsung Medical Center</investigator_affiliation>
    <investigator_full_name>KYU-SUNG LEE</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>Recurrent cystitis</keyword>
  <keyword>hyaluronic acid</keyword>
  <keyword>chondroitin sulphate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystitis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

